# Proto Labs, Inc. (PRLB) FY2026 Q2 Balance Sheet

- Company: Proto Labs, Inc. (PRLB)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-31, accession number 0001443669-26-000035
- Page: https://plicit.ai/financials/prlb/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/prlb-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 791,298,000 US dollars
- **Current assets**: 266,243,000 US dollars
- **Non-current assets**: 525,055,000 US dollars
- **Liabilities**: 99,565,000 US dollars
- **Current liabilities**: 73,204,000 US dollars
- **Non-current liabilities**: 26,361,000 US dollars
- **Equity**: 691,733,000 US dollars
- **Cash and cash equivalents**: 127,918,000 US dollars
- **Accounts receivable, net of allowance for credit losses of $3,022 and $2,668 as of June 30, 2026, and December 31, 2025, respectively**: 95,074,000 US dollars
- **Inventory**: 15,413,000 US dollars
- **Short-term marketable securities**: 14,858,000 US dollars
- **Prepaid expenses and other current assets**: 11,590,000 US dollars
- **Income taxes receivable**: 1,390,000 US dollars
- **Goodwill**: 273,991,000 US dollars
- **Property and equipment, net**: 208,329,000 US dollars
- **Long-term marketable securities**: 20,120,000 US dollars
- **Other intangible assets, net**: 16,606,000 US dollars
- **Other long-term assets**: 4,456,000 US dollars
- **Operating lease assets**: 1,263,000 US dollars
- **Finance lease assets**: 290,000 US dollars
- **Accrued liabilities and other**: 31,776,000 US dollars
- **Accounts payable**: 21,542,000 US dollars
- **Accrued compensation**: 18,830,000 US dollars
- **Current operating lease liabilities**: 929,000 US dollars
- **Current finance lease liabilities**: 127,000 US dollars
- **Long-term deferred tax liabilities**: 20,625,000 US dollars
- **Other long-term liabilities**: 4,551,000 US dollars
- **Long-term operating lease liabilities**: 1,185,000 US dollars
- **Additional paid-in capital**: 460,671,000 US dollars
- **Retained earnings**: 254,326,000 US dollars
- **Common stock, $0.001 par value, authorized 150,000,000 shares; issued and outstanding 23,921,897 and 23,627,422 shares as of June 30, 2026, and December 31, 2025, respectively**: 24,000 US dollars
- **Preferred stock, $0.001 par value, authorized 10,000,000 shares; issued and outstanding 0 shares as of June 30, 2026, and December 31, 2025, respectively**: 0 US dollars
- **Accumulated other comprehensive loss**: negative 23,288,000 US dollars
- **Gross equity (calculated)**: 715,021,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.